MDEA related death in crete: A case report and literature review

Veterinary and Human Toxicology

Volumn 39, Issue 4, 1997, Pages 241-244

  Tsatsakis, Aristidis M ^a   Michalodimitrakis, Manolis N ^a   Angelo, J D ^a   Patsalis, N ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; GREECE; HUMAN; INTOXICATION; KIDNEY INJURY; LIVER INJURY; MALE; MORTALITY; RHABDOMYOLYSIS; SUBSTANCE ABUSE;

3,4-METHYLENEDIOXYAMPHETAMINE; ADULT; DESIGNER DRUGS; FATAL OUTCOME; GREECE; HUMANS; MALE;

EID: 0030746927     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Evanko D: "Designer drugs". Postgrad Med 89: 67-70, 1991.
2. Buchanan JF, Brown CR: "Designer drugs": A problem in clinical toxicology. Med Toxicol Adverse Drug Exp 3: 1-17, 1988.
3. Russell AR, Schwartz RM, Dawling S: Accidental ingestion of "Ecstasy" (3,4-methylenedioxymethylamphetamine). Arch Dis Child 67: 1114-1115, 1992.
4. Henry JA, Jeffreys KJ, Dawling S: Toxicity and deaths from 3,4-methylenedioxymethamphetamine. Lancet, 340: 384-387, 1992.
5. Moreines R: The Psychedelics. In Ciannini AJ, Slaby AE eds: Drugs of Abuse. Economics Books, Oradell NJ: 207-241, 1989.
6. Corard DA, Davis SE, Clark ML: Misuse of Ecstasy. BMJ 305: 309, 1992.
7. Green AR, Cross AJ, Goodwin CM: Review of the, pharmacology and clinical pharmacology of 3,4-methylenedloxymethamphetamlne (MDMA or "Ecstasy"). Psychopharmacol 119: 247-260, 1995.
8. Khakoo SI, Coles CJ, Armstrong JC et al: Hepatotoxiclty and accelerated fibrosis following 3,4-methylenedloxymethamphetamine ("Ecstasy") usage. J Clin Castroenterol 20: 244-247, 1995.
9. Dowling CP, McDonough ET, Rost RO: Eve and Ecstasy. A report on five deaths associated nlth the use of MDEA and MDMA. JAMA 257: 1615-1617, 1987.
10. Fineschi V: Fatal poisoning by MDMA ("Ecstasy") and MDEA: A case report. Int J Legal Med 108: 272-275, 1996.
11. Milroy CM, Clark JC, Forrest ARW: Pathology of deaths associated with "Ecstasy" and "Eve" misuse. J Clin Pathol 49: 149- 153, 1996.
12. Lewis LA, Ross RW: The gay dance party culture in Sydney: A qualitative analysis. J Homosex 29: 49-70, 1995.
13. Wright JD, Pearl L: Knowledge and experience of young people regarding drug misuse 1969-1994. BMJ 310: 6971, 1995.
14. Marsch JC, Abboudi ZH, Gibsor FM et al: Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ("Ecstasy"). Br J Haematol 88: 281-285, 1994.
15. Dykhuizen RS, Brunt PH, Atkinson P et al: Ecstasy induced hepatitis mimicking viral hepatitis. Cut 36: 939-941, 1995.
16. Kramer HK, Poblete JC, Azmltla EC: 3,4-methylenedloxymethamphetamine ("Ecstasy") promotes the translocation of protein kinase (PKC): Requirement of viable serotonin nerve terminals. Brain Res 680: 1-2, 1995.
17. Tehan B, Harden R, Bodenham A: Hyperthermia associated with 3,4-methylenedfoxyethamphetamine ("Eve"). Anaesthesia 48: 507-510, 1993.
18. Dafters RI: Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption and chronic dosing. Physiol Behav 58: 877-882, 1995.
19. Bonime W: The myth of masochism. J Am Acad Psychoanal 23: 33-46, 1995.
20. Chadwick IS, Linsley A, Freemont AJ et al: Ecstasy, MDMA, a fatality associated with coagulopathy and hyperthermia. JR Soc Med 84: 371, 1991.
21. Brown C, Osterloh J: Multiple severe complications from recreational ingestion of MDMA ("Ecstasy"). JAMA 258: 780-781, 1987.
22. Colado MI, Williams JL, Green AR: The hyperthermic and neurotoxic effects of "Ecstasy" (MDMA) and 3,4-methylenedloxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br J Pharmacol 115: 1281- 1289, 1995.
23. Tsatsakis AM, Tsokalof AK, Siatitsas Y et al : Acute poisoning with carbamate pesticides: The Cretan experience. Science and Justice 36: 35-39, 1996.